Literature DB >> 15024144

Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia.

M-O Chandesris, S Gayet, N Schleinitz, B Doudier, J-Robert Harlé, G Kaplanski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15024144     DOI： 10.1093/rheumatology/keh080

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

Review 1.  Infection-related vasculitis.

Authors:  Omondi Oyoo; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 2.  Cutaneous vasculitis.

Authors:  Samina Hayat; Seth Mark Berney
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

3.  High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Emiliano Ghiri; Santino Marchi; Michele Colaci; Fabrizio Bruschi; Poupak Fallahi
Journal:  Clin Rheumatol       Date:  2009-06-20       Impact factor: 2.980

Review 4.  Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

Authors:  Chalermrat Bunchorntavakul; Robert Mitrani; K Rajender Reddy
Journal:  J Clin Exp Hepatol       Date:  2017-12-07

Review 5.  Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.

Authors:  Nuria Montero; Alexandre Favà; Eva Rodriguez; Clara Barrios; Josep M Cruzado; Julio Pascual; Maria Jose Soler
Journal:  Cochrane Database Syst Rev       Date:  2018-05-07

Review 6.  Anti-TNF-alpha therapy and systemic vasculitis.

Authors:  Pierre-André Jarrot; Gilles Kaplanski
Journal:  Mediators Inflamm       Date:  2014-02-27       Impact factor: 4.711

Review 7.  Managing refractory cryoglobulinemic vasculitis: challenges and solutions.

Authors:  Predrag Ostojic; Ivan R Jeremic
Journal:  J Inflamm Res       Date:  2017-05-08

Review 8.  The place of immunotherapy in the management of HCV-induced vasculitis: an update.

Authors:  Laurent Chiche; Stanislas Bataille; Gilles Kaplanski; Noemie Jourde
Journal:  Clin Dev Immunol       Date:  2012-08-15

9.  Therapy for vasculitic neuropathies.

Authors:  Kenneth C Gorson
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

10.  Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Authors:  Soledad Retamozo; Cándido Díaz-Lagares; Xavier Bosch; Albert Bové; Pilar Brito-Zerón; Maria-Eugenia Gómez; Jordi Yagüe; Xavier Forns; Maria C Cid; Manuel Ramos-Casals
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.